CD269 (BCMA) antibodies, human

Clone: REA315 | Dilution: 1:50
Clone REA315 recognizes the human CD269 antigen, a single-pass type III membrane protein which is also known as B cell maturation antigen (BCMA). CD269 is a member of the TNF-receptor superfamily that is preferentially expressed in mature B lymphocytes. It is the receptor for CD256 (TNFSF13, APRIL) and CD257 (TNFSF13B, BLyS, BAFF). CD269 promotes B cell survival and plays a role in the regulation of humoral immunity. Binding of CD269 to CD257 blocks the binding of CD257 to its receptor on the plasma membrane and inhibits CD257-triggered B lymphocyte costimulation. Overexpression of CD269 activates NF-κB and JNK, and this activation is potentiated by CD257.
Additional information: Clone REA315 displays negligible binding to Fc receptors.

Alternative Names


Technical specifications

  • Antigen: CD269 (BCMA)
  • Clone: REA315
  • Isotype: recombinant human IgG1
  • Isotype control: REA Control (S) antibodies
  • Alternative names of antigen: TNFRSF17, Bcm, BCMA
  • Entrez Gene ID: 608
  • Molecular mass of antigen [kDa]: 20
  • Distribution of antigen: lymphocytes, B cells
  • Product format: Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.
  • Fixation: Cells should be stained prior to fixation, if formaldehyde is used as a fixative.
  • Storage: Store protected from light at 2–8 °C. Do not freeze.
  • Available conjugates: PE, APC
Product options: 2

Product information

Order no.

CD269 (BCMA)-PE, human

  • REA315
  • 1:50
  • For research use only
for 30
EUR 90,00 

CD269 (BCMA)-PE, human

  • REA315
  • 1:50
  • For research use only
for 100
EUR 255,00 

Related products

3 products available